Floatz logo

TRIGLYCERIDES,MEDIUM CHAIN

Post Traumatic Stress Disorder

VA Office of Research and DevelopmentmixturePhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

22 Active assets in the Post Traumatic Stress Disorder cohort.

Asset / SponsorPhaseRating
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Queen's University
Phase 4BBB
Sertraline
Yang I. Pachankis, PhD
Phase 4BB
Paroxetine
University of Washington
Phase 4BB
Cipralex
New York State Psychiatric Institute
Phase 4BB
Methylphenidate
VA Office of Research and Development
Phase 4BB

View all 44 →

Same molecule, other indications

TRIGLYCERIDES,MEDIUM CHAIN is also rated in:

pancreatic neoplasmDormant
BB
Indicative ·
65 / 100
View asset →
gastric neoplasmDormant
BB
Indicative ·
65 / 100
View asset →
liver and intrahepatic bile duct neoplasmDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →